Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· April 13, 2026

Stock market today: Dow, S&P 500, Nasdaq trim losses after Trump orders Hormuz blockade against Iran

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq trim losses after Trump orders Hormuz blockade against Iran US stocks were mixed on Monday after President Trump ordered a US blockade of the Strait of Hormuz following the collapse of US-Iran negotiations…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • If Amazon pushes through $240, it would open door to retest all-time highs near $255-260

    60% confidence
  • United States Navy will begin blockading any and all ships trying to enter or leave the Strait of Hormuz effective immediately starting at 10 a.m. ET Monday

    60% confidence
  • Iran will target all Persian Gulf ports if its own energy hubs are threatened

    60% confidence
  • Bulls want to see Amazon $220-225 area hold on weakness, which lines up with 200-day moving average

    60% confidence
  • Amazon is running into downtrend line from early November high and early January peak, with $238-240 area repeatedly capping rallies since early 2025

    60% confidence
  • US blockade is an act of piracy

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com